Measuring Patient Persistency with Drug Therapy Using Methods for the Design and Analysis of Natural History Studies
Participating Faculty
Introduction
An Economic Analysis of Switching to Latanoprost from a Beta-Blocker or adding Brimonidine or Latanoprost to a Beta-Blocker in Open-Angle Glaucoma or Ocular Hypertension
Population-Based Persistency Rates for Topical Glaucoma Medications Measured with Pharmacy Claims Data
Rates of Discontinuation and Change of Glaucoma Therapy in a Managed Care Setting
Dicontinuation Rates of Topical Glaucoma Medications in a Managed Care Population
Measuring Persistency and Intraocular Pressure-Controlled Days in Patients Receiving Topical Glaucoma Medications
